Literature DB >> 3931833

Treatment with danazol and plasma glucagon concentration.

G Williams, F Lofts, H Fuessl, S Bloom.   

Abstract

The association between treatment with danazol and hyperglucagonaemia was studied. Plasma glucagon concentrations were measured during an oral glucose tolerance test in seven women taking danazol and six healthy controls not taking danazol. Results showed that treatment with danazol is associated with severe hyperglucagonaemia, and in three patients glucagon concentrations reached the range suggestive of glucagonoma. It is important to recognise that this increasingly used drug may cause severe hyperglucagonaemia to prevent patients treated with danazol undergoing unnecessary investigations to localise glucagonoma.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3931833      PMCID: PMC1417875          DOI: 10.1136/bmj.291.6503.1155

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  4 in total

1.  Metabolic effects of danazol.

Authors:  V Wynn
Journal:  J Int Med Res       Date:  1977       Impact factor: 1.671

2.  A glucagonoma syndrome.

Authors:  C N Mallinson; S R Bloom; A P Warin; P R Salmon; B Cox
Journal:  Lancet       Date:  1974-07-06       Impact factor: 79.321

3.  Dosage aspects of danazol therapy in the treatment of endometriosis.

Authors:  G D Ward
Journal:  Postgrad Med J       Date:  1979       Impact factor: 2.401

Review 4.  Hyperandrogenism, insulin resistance, and acanthosis nigricans syndrome: a common endocrinopathy with distinct pathophysiologic features.

Authors:  R L Barbieri; K J Ryan
Journal:  Am J Obstet Gynecol       Date:  1983-09-01       Impact factor: 8.661

  4 in total
  1 in total

1.  Severe hyperglucagonaemia during treatment with oxymetholone.

Authors:  G Williams; M Ghatei; J Burrin; S Bloom
Journal:  Br Med J (Clin Res Ed)       Date:  1986-06-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.